Table of Content

1 Anti-CD31 Antibody Market Overview
1.1 Anti-CD31 Antibody Product Overview
1.2 Anti-CD31 Antibody Market Segment by Type
1.2.1 Monoclonal
1.2.2 Polyclonal
1.3 Global Anti-CD31 Antibody Market Size by Type
1.3.1 Global Anti-CD31 Antibody Market Size Overview by Type (2018-2033)
1.3.2 Global Anti-CD31 Antibody Historic Market Size Review by Type (2018-2023)
1.3.3 Global Anti-CD31 Antibody Forecasted Market Size by Type (2024-2033)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Anti-CD31 Antibody Sales Breakdown by Type (2018-2023)
1.4.2 Europe Anti-CD31 Antibody Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Anti-CD31 Antibody Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Anti-CD31 Antibody Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Anti-CD31 Antibody Sales Breakdown by Type (2018-2023)
2 Global Anti-CD31 Antibody Market Competition by Company
2.1 Global Top Players by Anti-CD31 Antibody Sales (2018-2023)
2.2 Global Top Players by Anti-CD31 Antibody Revenue (2018-2023)
2.3 Global Top Players by Anti-CD31 Antibody Price (2018-2023)
2.4 Global Top Manufacturers Anti-CD31 Antibody Manufacturing Base Distribution, Sales Area, Product Type
2.5 Anti-CD31 Antibody Market Competitive Situation and Trends
2.5.1 Anti-CD31 Antibody Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Anti-CD31 Antibody Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Anti-CD31 Antibody as of 2022)
2.7 Date of Key Manufacturers Enter into Anti-CD31 Antibody Market
2.8 Key Manufacturers Anti-CD31 Antibody Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Anti-CD31 Antibody Status and Outlook by Region
3.1 Global Anti-CD31 Antibody Market Size and CAGR by Region: 2018 VS 2022 VS 2033
3.2 Global Anti-CD31 Antibody Historic Market Size by Region
3.2.1 Global Anti-CD31 Antibody Sales in Volume by Region (2018-2023)
3.2.2 Global Anti-CD31 Antibody Sales in Value by Region (2018-2023)
3.2.3 Global Anti-CD31 Antibody Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Anti-CD31 Antibody Forecasted Market Size by Region
3.3.1 Global Anti-CD31 Antibody Sales in Volume by Region (2024-2033)
3.3.2 Global Anti-CD31 Antibody Sales in Value by Region (2024-2033)
3.3.3 Global Anti-CD31 Antibody Sales (Volume & Value), Price and Gross Margin (2024-2033)
4 Global Anti-CD31 Antibody by Application
4.1 Anti-CD31 Antibody Market Segment by Application
4.1.1 Immunochemistry
4.1.2 Immunofluorescence
4.1.3 Immunoprecipitation
4.1.4 Western Blot
4.1.5 Others
4.2 Global Anti-CD31 Antibody Market Size by Application
4.2.1 Global Anti-CD31 Antibody Market Size Overview by Application (2018-2033)
4.2.2 Global Anti-CD31 Antibody Historic Market Size Review by Application (2018-2023)
4.2.3 Global Anti-CD31 Antibody Forecasted Market Size by Application (2024-2033)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Anti-CD31 Antibody Sales Breakdown by Application (2018-2023)
4.3.2 Europe Anti-CD31 Antibody Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Anti-CD31 Antibody Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Anti-CD31 Antibody Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Anti-CD31 Antibody Sales Breakdown by Application (2018-2023)
5 North America Anti-CD31 Antibody by Country
5.1 North America Anti-CD31 Antibody Historic Market Size by Country
5.1.1 North America Anti-CD31 Antibody Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2033
5.1.2 North America Anti-CD31 Antibody Sales in Volume by Country (2018-2023)
5.1.3 North America Anti-CD31 Antibody Sales in Value by Country (2018-2023)
5.2 North America Anti-CD31 Antibody Forecasted Market Size by Country
5.2.1 North America Anti-CD31 Antibody Sales in Volume by Country (2024-2033)
5.2.2 North America Anti-CD31 Antibody Sales in Value by Country (2024-2033)
6 Europe Anti-CD31 Antibody by Country
6.1 Europe Anti-CD31 Antibody Historic Market Size by Country
6.1.1 Europe Anti-CD31 Antibody Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2033
6.1.2 Europe Anti-CD31 Antibody Sales in Volume by Country (2018-2023)
6.1.3 Europe Anti-CD31 Antibody Sales in Value by Country (2018-2023)
6.2 Europe Anti-CD31 Antibody Forecasted Market Size by Country
6.2.1 Europe Anti-CD31 Antibody Sales in Volume by Country (2024-2033)
6.2.2 Europe Anti-CD31 Antibody Sales in Value by Country (2024-2033)
7 Asia-Pacific Anti-CD31 Antibody by Region
7.1 Asia-Pacific Anti-CD31 Antibody Historic Market Size by Region
7.1.1 Asia-Pacific Anti-CD31 Antibody Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2033
7.1.2 Asia-Pacific Anti-CD31 Antibody Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Anti-CD31 Antibody Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Anti-CD31 Antibody Forecasted Market Size by Region
7.2.1 Asia-Pacific Anti-CD31 Antibody Sales in Volume by Region (2024-2033)
7.2.2 Asia-Pacific Anti-CD31 Antibody Sales in Value by Region (2024-2033)
8 Latin America Anti-CD31 Antibody by Country
8.1 Latin America Anti-CD31 Antibody Historic Market Size by Country
8.1.1 Latin America Anti-CD31 Antibody Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2033
8.1.2 Latin America Anti-CD31 Antibody Sales in Volume by Country (2018-2023)
8.1.3 Latin America Anti-CD31 Antibody Sales in Value by Country (2018-2023)
8.2 Latin America Anti-CD31 Antibody Forecasted Market Size by Country
8.2.1 Latin America Anti-CD31 Antibody Sales in Volume by Country (2024-2033)
8.2.2 Latin America Anti-CD31 Antibody Sales in Value by Country (2024-2033)
9 Middle East and Africa Anti-CD31 Antibody by Country
9.1 Middle East and Africa Anti-CD31 Antibody Historic Market Size by Country
9.1.1 Middle East and Africa Anti-CD31 Antibody Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2033
9.1.2 Middle East and Africa Anti-CD31 Antibody Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Anti-CD31 Antibody Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Anti-CD31 Antibody Forecasted Market Size by Country
9.2.1 Middle East and Africa Anti-CD31 Antibody Sales in Volume by Country (2024-2033)
9.2.2 Middle East and Africa Anti-CD31 Antibody Sales in Value by Country (2024-2033)
10 Company Profiles
10.1 BosterBio
10.1.1 BosterBio Company Information
10.1.2 BosterBio Introduction and Business Overview
10.1.3 BosterBio Anti-CD31 Antibody Sales, Revenue and Gross Margin (2018-2023)
10.1.4 BosterBio Anti-CD31 Antibody Products Offered
10.1.5 BosterBio Recent Development
10.2 Bio-Rad
10.2.1 Bio-Rad Company Information
10.2.2 Bio-Rad Introduction and Business Overview
10.2.3 Bio-Rad Anti-CD31 Antibody Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Bio-Rad Anti-CD31 Antibody Products Offered
10.2.5 Bio-Rad Recent Development
10.3 BD Biosciences
10.3.1 BD Biosciences Company Information
10.3.2 BD Biosciences Introduction and Business Overview
10.3.3 BD Biosciences Anti-CD31 Antibody Sales, Revenue and Gross Margin (2018-2023)
10.3.4 BD Biosciences Anti-CD31 Antibody Products Offered
10.3.5 BD Biosciences Recent Development
10.4 Abcam
10.4.1 Abcam Company Information
10.4.2 Abcam Introduction and Business Overview
10.4.3 Abcam Anti-CD31 Antibody Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Abcam Anti-CD31 Antibody Products Offered
10.4.5 Abcam Recent Development
10.5 RayBiotech
10.5.1 RayBiotech Company Information
10.5.2 RayBiotech Introduction and Business Overview
10.5.3 RayBiotech Anti-CD31 Antibody Sales, Revenue and Gross Margin (2018-2023)
10.5.4 RayBiotech Anti-CD31 Antibody Products Offered
10.5.5 RayBiotech Recent Development
10.6 GeneTex
10.6.1 GeneTex Company Information
10.6.2 GeneTex Introduction and Business Overview
10.6.3 GeneTex Anti-CD31 Antibody Sales, Revenue and Gross Margin (2018-2023)
10.6.4 GeneTex Anti-CD31 Antibody Products Offered
10.6.5 GeneTex Recent Development
10.7 BioLegend
10.7.1 BioLegend Company Information
10.7.2 BioLegend Introduction and Business Overview
10.7.3 BioLegend Anti-CD31 Antibody Sales, Revenue and Gross Margin (2018-2023)
10.7.4 BioLegend Anti-CD31 Antibody Products Offered
10.7.5 BioLegend Recent Development
10.8 BMA Biomedicals
10.8.1 BMA Biomedicals Company Information
10.8.2 BMA Biomedicals Introduction and Business Overview
10.8.3 BMA Biomedicals Anti-CD31 Antibody Sales, Revenue and Gross Margin (2018-2023)
10.8.4 BMA Biomedicals Anti-CD31 Antibody Products Offered
10.8.5 BMA Biomedicals Recent Development
10.9 Bethyl Laboratories
10.9.1 Bethyl Laboratories Company Information
10.9.2 Bethyl Laboratories Introduction and Business Overview
10.9.3 Bethyl Laboratories Anti-CD31 Antibody Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Bethyl Laboratories Anti-CD31 Antibody Products Offered
10.9.5 Bethyl Laboratories Recent Development
10.10 SouthernBiotech
10.10.1 SouthernBiotech Company Information
10.10.2 SouthernBiotech Introduction and Business Overview
10.10.3 SouthernBiotech Anti-CD31 Antibody Sales, Revenue and Gross Margin (2018-2023)
10.10.4 SouthernBiotech Anti-CD31 Antibody Products Offered
10.10.5 SouthernBiotech Recent Development
10.11 Elabscience Biotechnology Inc
10.11.1 Elabscience Biotechnology Inc Company Information
10.11.2 Elabscience Biotechnology Inc Introduction and Business Overview
10.11.3 Elabscience Biotechnology Inc Anti-CD31 Antibody Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Elabscience Biotechnology Inc Anti-CD31 Antibody Products Offered
10.11.5 Elabscience Biotechnology Inc Recent Development
10.12 Merck
10.12.1 Merck Company Information
10.12.2 Merck Introduction and Business Overview
10.12.3 Merck Anti-CD31 Antibody Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Merck Anti-CD31 Antibody Products Offered
10.12.5 Merck Recent Development
10.13 Leica Biosystems
10.13.1 Leica Biosystems Company Information
10.13.2 Leica Biosystems Introduction and Business Overview
10.13.3 Leica Biosystems Anti-CD31 Antibody Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Leica Biosystems Anti-CD31 Antibody Products Offered
10.13.5 Leica Biosystems Recent Development
10.14 Beijing Solarbio Science & Technology
10.14.1 Beijing Solarbio Science & Technology Company Information
10.14.2 Beijing Solarbio Science & Technology Introduction and Business Overview
10.14.3 Beijing Solarbio Science & Technology Anti-CD31 Antibody Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Beijing Solarbio Science & Technology Anti-CD31 Antibody Products Offered
10.14.5 Beijing Solarbio Science & Technology Recent Development
10.15 Wuhan Fine Biotech
10.15.1 Wuhan Fine Biotech Company Information
10.15.2 Wuhan Fine Biotech Introduction and Business Overview
10.15.3 Wuhan Fine Biotech Anti-CD31 Antibody Sales, Revenue and Gross Margin (2018-2023)
10.15.4 Wuhan Fine Biotech Anti-CD31 Antibody Products Offered
10.15.5 Wuhan Fine Biotech Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Anti-CD31 Antibody Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Anti-CD31 Antibody Industrial Chain Analysis
11.4 Anti-CD31 Antibody Market Dynamics
11.4.1 Anti-CD31 Antibody Industry Trends
11.4.2 Anti-CD31 Antibody Market Drivers
11.4.3 Anti-CD31 Antibody Market Challenges
11.4.4 Anti-CD31 Antibody Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Anti-CD31 Antibody Distributors
12.3 Anti-CD31 Antibody Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Monoclonal
Table 2. Major Company of Polyclonal
Table 3. Global Anti-CD31 Antibody Sales by Type 2018 VS 2022 VS 2033 (US$ Million)
Table 4. Global Anti-CD31 Antibody Sales by Type (2018-2023) & (K Units)
Table 5. Global Anti-CD31 Antibody Sales Market Share in Volume by Type (2018-2023)
Table 6. Global Anti-CD31 Antibody Sales by Type (2018-2023) & (US& Million)
Table 7. Global Anti-CD31 Antibody Market Share in Value by Type (2018-2023)
Table 8. Global Anti-CD31 Antibody Price by Type (2018-2023) & (US$/Unit)
Table 9. Global Anti-CD31 Antibody Sales by Type (2024-2033) & (K Units)
Table 10. Global Anti-CD31 Antibody Sales Market Share in Volume by Type (2024-2033)
Table 11. Global Anti-CD31 Antibody Sales by Type (2024-2033) & (US$ Million)
Table 12. Global Anti-CD31 Antibody Sales Market Share in Value by Type (2024-2033)
Table 13. Global Anti-CD31 Antibody Price by Type (2024-2033) & (US$/Unit)
Table 14. North America Anti-CD31 Antibody Sales by Type (2018-2023) & (K Units)
Table 15. North America Anti-CD31 Antibody Sales by Type (2018-2023) & (US$ Million)
Table 16. Europe Anti-CD31 Antibody Sales (K Units) by Type (2018-2023)
Table 17. Europe Anti-CD31 Antibody Sales by Type (2018-2023) & (US$ Million)
Table 18. Asia-Pacific Anti-CD31 Antibody Sales (K Units) by Type (2018-2023)
Table 19. Asia-Pacific Anti-CD31 Antibody Sales by Type (2018-2023) & (US$ Million)
Table 20. Latin America Anti-CD31 Antibody Sales (K Units) by Type (2018-2023)
Table 21. Latin America Anti-CD31 Antibody Sales by Type (2018-2023) & (US$ Million)
Table 22. Middle East and Africa Anti-CD31 Antibody Sales (K Units) by Type (2018-2023)
Table 23. Middle East and Africa Anti-CD31 Antibody Sales by Type (2018-2023) & (US$ Million)
Table 24. Global Anti-CD31 Antibody Sales by Company (2018-2023) & (K Units)
Table 25. Global Anti-CD31 Antibody Sales Share by Company (2018-2023)
Table 26. Global Anti-CD31 Antibody Revenue by Company (2018-2023) & (US$ Million)
Table 27. Global Anti-CD31 Antibody Revenue Share by Company (2018-2023)
Table 28. Global Market Anti-CD31 Antibody Price by Company (2018-2023) & (US$/Unit)
Table 29. Global Anti-CD31 Antibody Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Anti-CD31 Antibody Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Anti-CD31 Antibody as of 2022)
Table 32. Date of Key Manufacturers Enter into Anti-CD31 Antibody Market
Table 33. Key Manufacturers Anti-CD31 Antibody Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Anti-CD31 Antibody Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2033
Table 36. Global Anti-CD31 Antibody Sales by Region (2018-2023) & (K Units)
Table 37. Global Anti-CD31 Antibody Sales Market Share in Volume by Region (2018-2023)
Table 38. Global Anti-CD31 Antibody Sales by Region (2018-2023) & (US$ Million)
Table 39. Global Anti-CD31 Antibody Sales Market Share in Value by Region (2018-2023)
Table 40. Global Anti-CD31 Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 41. Global Anti-CD31 Antibody Sales by Region (2024-2033) & (K Units)
Table 42. Global Anti-CD31 Antibody Sales Market Share in Volume by Region (2024-2033)
Table 43. Global Anti-CD31 Antibody Sales by Region (2024-2033) & (US$ Million)
Table 44. Global Anti-CD31 Antibody Sales Market Share in Value by Region (2024-2033)
Table 45. Global Anti-CD31 Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2033)
Table 46. Global Anti-CD31 Antibody Sales by Application: 2018 VS 2022 VS 2033 (US$ Million)
Table 47. Global Anti-CD31 Antibody Sales by Application (2018-2023) & (K Units)
Table 48. Global Anti-CD31 Antibody Sales Market Share in Volume by Application (2018-2023)
Table 49. Global Anti-CD31 Antibody Sales by Application (2018-2023) & (US$ Million)
Table 50. Global Anti-CD31 Antibody Sales Market Share in Value by Application (2018-2023)
Table 51. Global Anti-CD31 Antibody Price by Application (2018-2023) & (US$/Unit)
Table 52. Global Anti-CD31 Antibody Sales by Application (2024-2033) & (K Units)
Table 53. Global Anti-CD31 Antibody Sales Market Share in Volume by Application (2024-2033)
Table 54. Global Anti-CD31 Antibody Sales by Application (2024-2033) & (US$ Million)
Table 55. Global Anti-CD31 Antibody Sales Market Share in Value by Application (2024-2033)
Table 56. Global Anti-CD31 Antibody Price by Application (2024-2033) & (US$/Unit)
Table 57. North America Anti-CD31 Antibody Sales by Application (2018-2023) (K Units)
Table 58. North America Anti-CD31 Antibody Sales by Application (2018-2023) & (US$ Million)
Table 59. Europe Anti-CD31 Antibody Sales by Application (2018-2023) (K Units)
Table 60. Europe Anti-CD31 Antibody Sales by Application (2018-2023) & (US$ Million)
Table 61. Asia-Pacific Anti-CD31 Antibody Sales by Application (2018-2023) (K Units)
Table 62. Asia-Pacific Anti-CD31 Antibody Sales by Application (2018-2023) & (US$ Million)
Table 63. Latin America Anti-CD31 Antibody Sales by Application (2018-2023) (K Units)
Table 64. Latin America Anti-CD31 Antibody Sales by Application (2018-2023) & (US$ Million)
Table 65. Middle East and Africa Anti-CD31 Antibody Sales by Application (2018-2023) (K Units)
Table 66. Middle East and Africa Anti-CD31 Antibody Sales by Application (2018-2023) & (US$ Million)
Table 67. North America Anti-CD31 Antibody Sales by Country (2018-2023) & (K Units)
Table 68. North America Anti-CD31 Antibody Sales Market Share in Volume by Country (2018-2023)
Table 69. North America Anti-CD31 Antibody Sales by Country (2018-2023) & (US$ Million)
Table 70. North America Anti-CD31 Antibody Sales Market Share in Value by Country (2018-2023)
Table 71. North America Anti-CD31 Antibody Sales by Country (2024-2033) & (K Units)
Table 72. North America Anti-CD31 Antibody Sales Market Share in Volume by Country (2024-2033)
Table 73. North America Anti-CD31 Antibody Sales by Country (2024-2033) & (US$ Million)
Table 74. North America Anti-CD31 Antibody Sales Market Share in Value by Country (2024-2033)
Table 75. Europe Anti-CD31 Antibody Sales by Country (2018-2023) & (K Units)
Table 76. Europe Anti-CD31 Antibody Sales Market Share in Volume by Country (2018-2023)
Table 77. Europe Anti-CD31 Antibody Sales by Country (2018-2023) & (US$ Million)
Table 78. Europe Anti-CD31 Antibody Sales Market Share in Value by Country (2018-2023)
Table 79. Europe Anti-CD31 Antibody Sales by Country (2024-2033) & (K Units)
Table 80. Europe Anti-CD31 Antibody Sales Market Share in Volume by Country (2024-2033)
Table 81. Europe Anti-CD31 Antibody Sales by Country (2024-2033) & (US$ Million)
Table 82. Europe Anti-CD31 Antibody Sales Market Share in Value by Country (2024-2033)
Table 83. Asia-Pacific Anti-CD31 Antibody Sales by Region (2018-2023) & (K Units)
Table 84. Asia-Pacific Anti-CD31 Antibody Sales Market Share in Volume by Region (2018-2023)
Table 85. Asia-Pacific Anti-CD31 Antibody Sales by Region (2018-2023) & (US$ Million)
Table 86. Asia-Pacific Anti-CD31 Antibody Sales Market Share in Value by Region (2018-2023)
Table 87. Asia-Pacific Anti-CD31 Antibody Sales by Region (2024-2033) & (K Units)
Table 88. Asia-Pacific Anti-CD31 Antibody Sales Market Share in Volume by Region (2024-2033)
Table 89. Asia-Pacific Anti-CD31 Antibody Sales by Region (2024-2033) & (US$ Million)
Table 90. Asia-Pacific Anti-CD31 Antibody Sales Market Share in Value by Region (2024-2033)
Table 91. Latin America Anti-CD31 Antibody Sales by Country (2018-2023) & (K Units)
Table 92. Latin America Anti-CD31 Antibody Sales Market Share in Volume by Country (2018-2023)
Table 93. Latin America Anti-CD31 Antibody Sales by Country (2018-2023) & (US$ Million)
Table 94. Latin America Anti-CD31 Antibody Sales Market Share in Value by Country (2018-2023)
Table 95. Latin America Anti-CD31 Antibody Sales by Country (2024-2033) & (K Units)
Table 96. Latin America Anti-CD31 Antibody Sales Market Share in Volume by Country (2024-2033)
Table 97. Latin America Anti-CD31 Antibody Sales by Country (2024-2033) & (US$ Million)
Table 98. Latin America Anti-CD31 Antibody Sales Market Share in Value by Country (2024-2033)
Table 99. Middle East and Africa Anti-CD31 Antibody Sales by Country (2018-2023) & (K Units)
Table 100. Middle East and Africa Anti-CD31 Antibody Sales Market Share in Volume by Country (2018-2023)
Table 101. Middle East and Africa Anti-CD31 Antibody Sales by Country (2018-2023) & (US$ Million)
Table 102. Middle East and Africa Anti-CD31 Antibody Sales Market Share in Value by Country (2018-2023)
Table 103. Middle East and Africa Anti-CD31 Antibody Sales by Country (2024-2033) & (K Units)
Table 104. Middle East and Africa Anti-CD31 Antibody Sales Market Share in Volume by Country (2024-2033)
Table 105. Middle East and Africa Anti-CD31 Antibody Sales by Country (2024-2033) & (US$ Million)
Table 106. Middle East and Africa Anti-CD31 Antibody Sales Market Share in Value by Country (2024-2033)
Table 107. BosterBio Company Information
Table 108. BosterBio Introduction and Business Overview
Table 109. BosterBio Anti-CD31 Antibody Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 110. BosterBio Anti-CD31 Antibody Product
Table 111. BosterBio Recent Development
Table 112. Bio-Rad Company Information
Table 113. Bio-Rad Introduction and Business Overview
Table 114. Bio-Rad Anti-CD31 Antibody Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 115. Bio-Rad Anti-CD31 Antibody Product
Table 116. Bio-Rad Recent Development
Table 117. BD Biosciences Company Information
Table 118. BD Biosciences Introduction and Business Overview
Table 119. BD Biosciences Anti-CD31 Antibody Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 120. BD Biosciences Anti-CD31 Antibody Product
Table 121. BD Biosciences Recent Development
Table 122. Abcam Company Information
Table 123. Abcam Introduction and Business Overview
Table 124. Abcam Anti-CD31 Antibody Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 125. Abcam Anti-CD31 Antibody Product
Table 126. Abcam Recent Development
Table 127. RayBiotech Company Information
Table 128. RayBiotech Introduction and Business Overview
Table 129. RayBiotech Anti-CD31 Antibody Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 130. RayBiotech Anti-CD31 Antibody Product
Table 131. RayBiotech Recent Development
Table 132. GeneTex Company Information
Table 133. GeneTex Introduction and Business Overview
Table 134. GeneTex Anti-CD31 Antibody Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 135. GeneTex Anti-CD31 Antibody Product
Table 136. GeneTex Recent Development
Table 137. BioLegend Company Information
Table 138. BioLegend Introduction and Business Overview
Table 139. BioLegend Anti-CD31 Antibody Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 140. BioLegend Anti-CD31 Antibody Product
Table 141. BioLegend Recent Development
Table 142. BMA Biomedicals Company Information
Table 143. BMA Biomedicals Introduction and Business Overview
Table 144. BMA Biomedicals Anti-CD31 Antibody Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 145. BMA Biomedicals Anti-CD31 Antibody Product
Table 146. BMA Biomedicals Recent Development
Table 147. Bethyl Laboratories Company Information
Table 148. Bethyl Laboratories Introduction and Business Overview
Table 149. Bethyl Laboratories Anti-CD31 Antibody Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 150. Bethyl Laboratories Anti-CD31 Antibody Product
Table 151. Bethyl Laboratories Recent Development
Table 152. SouthernBiotech Company Information
Table 153. SouthernBiotech Introduction and Business Overview
Table 154. SouthernBiotech Anti-CD31 Antibody Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 155. SouthernBiotech Anti-CD31 Antibody Product
Table 156. SouthernBiotech Recent Development
Table 157. Elabscience Biotechnology Inc Company Information
Table 158. Elabscience Biotechnology Inc Introduction and Business Overview
Table 159. Elabscience Biotechnology Inc Anti-CD31 Antibody Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 160. Elabscience Biotechnology Inc Anti-CD31 Antibody Product
Table 161. Elabscience Biotechnology Inc Recent Development
Table 162. Merck Company Information
Table 163. Merck Introduction and Business Overview
Table 164. Merck Anti-CD31 Antibody Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 165. Merck Anti-CD31 Antibody Product
Table 166. Merck Recent Development
Table 167. Leica Biosystems Company Information
Table 168. Leica Biosystems Introduction and Business Overview
Table 169. Leica Biosystems Anti-CD31 Antibody Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 170. Leica Biosystems Anti-CD31 Antibody Product
Table 171. Leica Biosystems Recent Development
Table 172. Beijing Solarbio Science & Technology Company Information
Table 173. Beijing Solarbio Science & Technology Introduction and Business Overview
Table 174. Beijing Solarbio Science & Technology Anti-CD31 Antibody Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 175. Beijing Solarbio Science & Technology Anti-CD31 Antibody Product
Table 176. Beijing Solarbio Science & Technology Recent Development
Table 177. Wuhan Fine Biotech Company Information
Table 178. Wuhan Fine Biotech Introduction and Business Overview
Table 179. Wuhan Fine Biotech Anti-CD31 Antibody Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 180. Wuhan Fine Biotech Anti-CD31 Antibody Product
Table 181. Wuhan Fine Biotech Recent Development
Table 182. Key Raw Materials Lists
Table 183. Raw Materials Key Suppliers Lists
Table 184. Anti-CD31 Antibody Market Trends
Table 185. Anti-CD31 Antibody Market Drivers
Table 186. Anti-CD31 Antibody Market Challenges
Table 187. Anti-CD31 Antibody Market Restraints
Table 188. Anti-CD31 Antibody Distributors List
Table 189. Anti-CD31 Antibody Downstream Customers
Table 190. Research Programs/Design for This Report
Table 191. Key Data Information from Secondary Sources
Table 192. Key Data Information from Primary Sources
List of Figures
Figure 1. Anti-CD31 Antibody Product Picture
Figure 2. Global Anti-CD31 Antibody Market Size, 2018 VS 2022 VS 2033 (US$ Million)
Figure 3. Global Anti-CD31 Antibody Market Size Status and Outlook (2018-2033) & (US$ Million)
Figure 4. Global Anti-CD31 Antibody Sales Status and Outlook (2018-2033) & (K Units)
Figure 5. Product Picture of Monoclonal
Figure 6. Global Monoclonal Sales YoY Growth (2018-2033) & (K Units)
Figure 7. Product Picture of Polyclonal
Figure 8. Global Polyclonal Sales YoY Growth (2018-2033) & (K Units)
Figure 9. Global Anti-CD31 Antibody Sales by Type (2018-2033) & (US$ Million)
Figure 10. Global Anti-CD31 Antibody Sales Market Share by Type in 2022 & 2033
Figure 11. North America Anti-CD31 Antibody Sales Market Share in Volume by Type in 2022
Figure 12. North America Anti-CD31 Antibody Sales Market Share in Value by Type in 2022
Figure 13. Europe Anti-CD31 Antibody Sales Market Share in Volume by Type in 2022
Figure 14. Europe Anti-CD31 Antibody Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Anti-CD31 Antibody Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Anti-CD31 Antibody Sales Market Share in Value by Type in 2022
Figure 17. Latin America Anti-CD31 Antibody Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Anti-CD31 Antibody Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Anti-CD31 Antibody Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Anti-CD31 Antibody Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Anti-CD31 Antibody Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Anti-CD31 Antibody Revenue in 2022
Figure 23. Anti-CD31 Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. Product Picture of Immunochemistry
Figure 25. Global Immunochemistry Sales YoY Growth (2018-2033) & (K Units)
Figure 26. Product Picture of Immunofluorescence
Figure 27. Global Immunofluorescence Sales YoY Growth (2018-2033) & (K Units)
Figure 28. Product Picture of Immunoprecipitation
Figure 29. Global Immunoprecipitation Sales YoY Growth (2018-2033) & (K Units)
Figure 30. Product Picture of Western Blot
Figure 31. Global Western Blot Sales YoY Growth (2018-2033) & (K Units)
Figure 32. Product Picture of Others
Figure 33. Global Others Sales YoY Growth (2018-2033) & (K Units)
Figure 34. Global Anti-CD31 Antibody Sales by Application (2018-2033) & (US$ Million)
Figure 35. Global Anti-CD31 Antibody Sales Market Share by Application in 2022 & 2033
Figure 36. North America Anti-CD31 Antibody Sales Market Share in Volume by Application in 2022
Figure 37. North America Anti-CD31 Antibody Sales Market Share in Value by Application in 2022
Figure 38. Europe Anti-CD31 Antibody Sales Market Share in Volume by Application in 2022
Figure 39. Europe Anti-CD31 Antibody Sales Market Share in Value by Application in 2022
Figure 40. Asia-Pacific Anti-CD31 Antibody Sales Market Share in Volume by Application in 2022
Figure 41. Asia-Pacific Anti-CD31 Antibody Sales Market Share in Value by Application in 2022
Figure 42. Latin America Anti-CD31 Antibody Sales Market Share in Volume by Application in 2022
Figure 43. Latin America Anti-CD31 Antibody Sales Market Share in Value by Application in 2022
Figure 44. Middle East and Africa Anti-CD31 Antibody Sales Market Share in Value by Application in 2022
Figure 45. Key Raw Materials Price
Figure 46. Anti-CD31 Antibody Manufacturing Cost Structure
Figure 47. Anti-CD31 Antibody Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed